CEO Dr. William Jow of Medifocus, Inc. (OTCQB: MDFZF)(TSX.v: MFS), joins Stock Day to talk in detail about the development of The Prolieve System, the advantage of it's use versus other treatments, and plans to fight prostate and breast cancers.

OTCQB: MDFZF # TSX.v: MFS # focused microwave energy # cancer treatments # tumors # treatment of BPH # Adaptive Phased Array # APA 1000 Breast Cancer Treatment System # catheter-basis focused heat technology # Endo-thermotherapy Platform # fully developed technology platforms # Health Canada # healthcare # licensed, medical # Microwave # Focusing Platform-invented by MIT # Phase 3 Trials